Detalles de la búsqueda
1.
How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments.
Value Health
; 24(8): 1137-1144, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34372979
2.
Personalized benefit-risk assessments combining clinical trial and real-world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapy.
Pharmacoepidemiol Drug Saf
; 28(4): 443-451, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30848010
3.
Efficacy of Mobocertinib and Amivantamab in Patients With Advanced Non-Small Cell Lung Cancer With EGFR Exon 20 Insertions Previously Treated With Platinum-Based Chemotherapy: An Indirect Treatment Comparison.
Clin Lung Cancer
; 25(3): e145-e152.e3, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38114357
4.
Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison.
Adv Ther
; 40(7): 3087-3103, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37208556
5.
Indirect comparison of mobocertinib and real-world therapies for pre-treated non-small cell lung cancer with EGFR exon 20 insertion mutations.
Lung Cancer
; 179: 107191, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37058788
6.
Tafasitamab Plus Lenalidomide Versus 3 Rituximab-Based Treatments for Non-Transplant Eligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Matching-Adjusted Indirect Comparison.
Adv Ther
; 39(6): 2668-2687, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35403948
7.
Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessment.
J Clin Epidemiol
; 144: 84-92, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34856367
8.
DREAMM-2: Indirect Comparisons of Belantamab Mafodotin vs. Selinexor + Dexamethasone and Standard of Care Treatments in Relapsed/Refractory Multiple Myeloma.
Adv Ther
; 38(11): 5501-5518, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34561812
9.
Assessment-Schedule Matching in Unanchored Indirect Treatment Comparisons of Progression-Free Survival in Cancer Studies.
Pharmacoeconomics
; 37(12): 1537-1551, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31555968
Resultados
1 -
9
de 9
1
Próxima >
>>